Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Journal of Experimental Hematology ; (6): 1899-1904, 2023.
Article in Chinese | WPRIM | ID: wpr-1010057

ABSTRACT

Graft-versus-host disease (GVHD) is one of the major complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT), which seriously affects the prognosis of patients. At present, a new regimen of post-transplantation cyclophosphamide (PTCy) combined with antithymocyte globulin (ATG) has been used to prevent GVHD, indicating that PTCy combined with ATG may have a good effect on the prevention of GVHD in different types of transplantation. However, the mechanism of this regimen, its effect on immune reconstitution and viral reactivation still needs to be further studied. Therefore, this article briefly reviews the research progress of PTCy combined with ATG in preventing GVHD after HSCT.


Subject(s)
Humans , Antilymphocyte Serum , Cyclophosphamide , Hematopoietic Stem Cell Transplantation/adverse effects , Graft vs Host Disease/prevention & control , Transplantation, Homologous , Retrospective Studies
2.
Chinese Journal of Clinical Pharmacology and Therapeutics ; (12): 295-301, 2022.
Article in Chinese | WPRIM | ID: wpr-1014879

ABSTRACT

AIM: To investigate the therapeutic method of fludarabine combined with subsequent cyclophosphamide in the prevention of GVHD in haploid hematopoietic stem cell transplantation. METHODS: A total of 52 patients receiving PTCY (50 mg/kg, on days 3 and 4) were matched with 29 patients receiving ATG. RESULTS: The median follow-up time was 359 days. Complete donor chimerism was achieved in all patients by STR DNA detection on days +30, +60. The median time to neutrophils ≥0.5×10

SELECTION OF CITATIONS
SEARCH DETAIL